Trial · NCT07600151
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
NCT07600151, Phase 1, Phase 2, Not yet recruiting, Universitätsklinikum Hamburg-Eppendorf
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma. Trials, record NCT07600151. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07600151
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
- NCT number
- NCT07600151
- Status
- Not yet recruiting
- Phases
- Phase 1, Phase 2
- Enrollment
- 220 participants, estimated
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Conditions
- Myeloma Multiple, Myeloma
- Interventions
- Etentamig, Isatuximab, Bortezomib + Lenalidomide + Dexamethasone
- First posted
- 2026-05-20
- Last updated
- 2026-05-20
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Safety and tolerability (Phase I) | through induction treatment, on average 4 months | Number of dose-limiting toxicities (DLTs) in participants and rates of adverse events (AEs) of grade ≥2 and of severe AEs in participants |
| Primary | MRD negativity (Phase II) | through consolidation phase completion, an average of 1 year | MRD-negativity rate after 12 cycles (with a sensitivity of \<10-5) |
| Primary | PFS | up to 10 years | Progression-free survival |
| Secondary | ORR | up to 10 years | Overall response rate |
| Secondary | CR rate | up to 10 years | Complete Response Rate |
| Secondary | VGPR Rate | up to 10 years | Very good partial response rate |
| Secondary | DoR | up to 10 years | Duration of Response |
| Secondary | TTR | up to 10 years | Time to response |
| Secondary | PFS2 | up to 10 years | Progression free survival 2 |
| Secondary | OS | up to 10 years | Overall survival |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07600151
GET https://conductscience.org/api/trials/v1/NCT07600151/registered